Oxygenated metabolites of polyunsaturated fatty acids: Formation and function in blood and vascular cells

European Journal of Lipid Science and Technology

Volumn 112, Issue 9, 2010, Pages 941-947

  Lagarde, Michel ^a  

^a Univ Lyon   (France)

Author keywords

Blood and vascular cells; Lipid mediators; Oxygenases; Polyunsaturated fatty acids

Indexed keywords

EID: 77956978185     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.201000045     Document Type: Article

References (49)

1. Samuelsson, B., Goldyne, M., Granström, E., Hamberg, M., et al., Prostaglandins and thromboxanes. Annu. Rev. Biochem. 1978, 47, 997-1029.
2. Narumiya, S., Sugimoto, Y., Ushikubi, F., Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 1999, 79, 1193-1226.
3. Lagarde, M., Gualde, N., Rigaud, M., Metabolic interactions between eicosanoids in blood and vascular cells. Biochem. J. 1989, 257, 313-320.
4. Samuelsson, B., Haeggström, J. Z., Wetterholm, A., Leukotriene biosynthesis. Ann. N. Y. Acad. Sci. 1991, 629, 89-99.
5. Titos, E., Chiang, N., Serhan, C. N., Romano, M., et al., Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4). Am. J. Physiol. 1999, 277, C870-C877.
6. Pouliot, M., Clish, C. B., Petasis, N. A., Van Dyke, T. E., Serhan, C. N., Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry. 2000, 39, 4761-4768.
7. Spector, A. A., Arachidonic acid cytochrome P450 epoxygenase pathway. J. Lipid Res. 2009, 50 Suppl. S52-S56.
8. Fang, X., Faraci, F. M., Kaduce, T. L., Harmon, S., et al., 20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase. Am. J. Physiol. Heart Circ. Physiol. 2006, 291, H2301-H2307.
9. Lagarde, M., Gharib, A., Dechavanne, M., Different utilization of arachidonic and dihomogammalinolenic acids by human platelet prostaglandin synthetase. Biochimie 1977, 59, 935-937.
10. Dutta-Roy, A. K., Kahn, N. N., Sinha, A. K., Interaction of receptors for prostaglandin E1/prostacyclin and insulin in human erythrocytes and platelets. Life Sci. 1991, 49, 1129-1139.
11. Needleman, P., Raz, A., Minkes, M. S., Ferrendelli, J. A., Sprecher, H., Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc. Natl. Acad. Sci. USA 1979, 76, 944-948.
12. Careaga, M. M., Sprecher, H., Metabolism of 8,11,14,17-eicosatetraenoic acid by human platelet lipoxygenase and cyclooxygenase. Biochim. Biophys. Acta 1987, 920, 94-101.
13. Lagarde, M., Burtin, M., Rigaud, M., Sprecher, H., et al., Prostaglandin E2-like activity of 20:3n-9 platelet lipoxygenase end-product. FEBS Lett. 1985, 181, 53-56.
14. Lagarde, M., Drouot, B., Guichardant, M., Dechavanne, M., In vitro incorporation and metabolism of some icosaenoic acids in platelets. Effect on arachidonic acid oxygenation. Biochim. Biophys. Acta 1985, 833, 52-58.
15. Boukhchache, D., Lagarde, M., Interactions between prostaglandin precursors during their oxygenation by human platelets. Biochim. Biophys. Acta 1982, 713, 386-392.
16. Morita, I., Takahashi, R., Saito, Y., Murota, S., Stimulation of eicosapentaenoic acid metabolism in washed human platelets by 12-hydroperoxyeicosatetraenoic acid. J. Biol. Chem. 1983, 258, 10197-10199.
17. Croset, M., Lagarde, M., Enhancement of eicosaenoic acid lipoxygenation in human platelets by 12-hydroperoxy derivative of arachidonic acid. Lipids 1985, 20, 743-750.
18. Bordet, J. C., Guichardant, M., Lagarde, M., Arachidonic acid strongly stimulates prostaglandin I3 (PGI3) production from eicosapentaenoic acid in human endothelial cells. Biochem. Biophys. Res. Commun. 1986, 135, 403-410.
19. Hornstra, G., Christ-Hazelhof, E., Haddeman, E., ten Hoor, F., et al., Fish oil feeding lowers thromboxane-and prostacyclin production by rat platelets and aorta and does not result in the formation of prostaglandin I3. Prostaglandins 1981, 21, 727-738.
20. Fischer, S., Weber, P. C., Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid. Nature 1984, 307, 165-168.
21. Buchanan, M. R., Haas, T. A., Lagarde, M., Guichardant, M., 13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX. J. Biol. Chem. 1985, 260, 16056-16059.
22. Kaduce, T. L., Figard, P. H., Leifur, R., Spector, A. A., Formation of 9-hydroxyoctadecadienoic acid from linoleic acid in endothelial cells. J. Biol. Chem. 1989, 264, 6823-6830.
23. Delerive, P., Furman, C., Teissier, E., Fruchart, J., et al., Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner. FEBS Lett. 2000, 471, 34-38.
24. Zuo, X., Wu, Y., Morris, J. S., Stimmel, J. B., et al., Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity. Oncogene 2006, 25, 1225-1241.
25. Folcik, V. A., Cathcart, M. K., Predominance of esterified hydroperoxy-linoleic acid in human monocyte-oxidized LDL. J. Lipid Res. 1994, 35, 1570-1582.
26. Ku, G., Thomas, C. E., Akeson, A. L., Jackson, R. L., Induction of interleukin 1 beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J. Biol. Chem. 1992, 267, 14183-14188.
27. Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H., et al., LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998, 93, 229-240.
28. Browse, J., Jasmonate: an oxylipin signal with many roles in plants. Vitam. Horm. 2005, 72, 431-456.
29. Laneuville, O., Breuer, D. K., Xu, N., Huang, Z. H., et al., Fatty acid substrate specificities of human prostaglandinendoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)-octadecatrienoic acids from alpha-linolenic acid. J. Biol. Chem. 1995, 270, 19330-19336.
30. VanRollins, M., Horrocks, L., Sprecher, H., Metabolism of 7,10,13,16-docosatetraenoic acid to dihomo-thromboxane, 14-hydroxy-7,10,12-nonadecatrienoic acid and hydroxy fatty acids by human platelets. Biochim. Biophys. Acta 1985, 833, 272-280.
31. Campbell, W. B., Falck, J. R., Okita, J. R., Johnson, A. R., Callahan, K. S., Synthesis of dihomoprostaglandins from adrenic acid (7,10,13,16-docosatetraenoic acid) by human endothelial cells. Biochim. Biophys. Acta 1985, 837, 67-76.
32. Bordet, J. C., Guichardant, M., Lagarde, M., Hydroperoxides produced by n-6 lipoxygenation of arachidonic and linoleic acids potentiate synthesis of prostacyclin related compounds. Biochim. Biophys. Acta 1988, 958, 458-460.
33. Harkewicz, R., Fahy, E., Andreyev, A., Dennis, E. A., Arachidonate-derived dihomoprostaglandin production observed in endotoxin-stimulated macrophage-like cells. J. Biol. Chem. 2007, 282, 2899-2910.
34. Milks, M. M., Sprecher, H., Metabolism of 4,7,10,13,16-docosapentaenoic acid by human platelet cyclooxygenase and lipoxygenase. Biochim. Biophys. Acta 1985, 835, 29-35.
35. Dangi, B., Obeng, M., Nauroth, J. M., Teymourlouei, M., et al., Biogenic synthesis, purification, and chemical characterization of anti-inflammatory resolvins derived from docosapentaenoic acid (DPAn-6). J. Biol. Chem. 2009, 284, 14744-14759.
36. Guichardant, M., Lagarde, M., Studies on platelet lipoxygenase specificity towards icosapolyenoic and docosapolyenoic acids. Biochim. Biophys. Acta 1985, 836, 204-210.
37. Aveldan?o, M. I., Sprecher, H., Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1-14C] docosahexaenoic acid by human platelets. J. Biol. Chem. 1983, 258, 9339-9343.
38. Croset, M., Sala, A., Folco, G., Lagarde, M., Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle. 14-Hydroxy from 22:6n-3 is more potent than 12-HETE. Biochem. Pharmacol. 1988, 37, 1275-1280.
39. Serhan, C. N., Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Curr. Opin. Clin. Nutr. Metab. Care 2005, 8, 115-121.
40. Ariel, A., Serhan, C. N., Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007, 28, 176-183.
41. Spite, M., Norling, L. V., Summers, L., Yang, R., et al., Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 2009, 461, 1287-1291.
42. Hong, S., Gronert, K., Devchand, P. R., Moussignac, R. L., Serhan, C. N., Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 2003, 278, 14677-14687.
43. Marcheselli, V. L., Mukherjee, P. K., Arita, M., Hong, S., et al., Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukot. Essent. Fatty Acids 2010, 82, 27-34.
44. Serhan, C. N., Gotlinger, K., Hong, S., Lu, Y., et al., Antiinflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxycontaining docosatrienes. J. Immunol. 2006, 176, 1848-1859.
45. Lukiw, W. J., Cui, J. G., Marcheselli, V. L., Bodker, M., et al., A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 2005, 115, 2774-2783.
46. Chen, P., Fenet, B., Michaud, S., Tomczyk, N., et al., Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation. FEBS Lett. 2009, 583, 3478-3484.
47. Croset, M., Lagarde, M., Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids. Biochem. Biophys. Res. Commun. 1983, 112, 878-883.
48. Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., et al., Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 2009, 206, 215-223.
49. Lagarde, M., Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function. Prog. Lipid Res. 1988, 27, 135-152.